Revelation Biosciences Inc (REVB) Return on Sales by Net Profit

Official company branding of Revelation Biosciences, Inc. (REVB)

The stability of Revelation Biosciences (REVB) is constrained by the risks of failed tests and a lack of profitability. The business foundation relies on the development of immune activation agents, while financial health is sustained by institutional investments. The current net profit margin, which the GURU.Markets system illustrates in this chart, confirms high volatility, with the latest reading standing at 0.00.

Revelation Biosciences (REVB) - Net Margin from 07/04/2022 to 11/19/2026

REVB (Revelation Biosciences): analytical breakdowns and indicator data

Fundamental company valuation:Revelation Biosciences Inc - REVB
Flagship merchandise of Revelation Biosciences Corp

Net profit margin determines the share of profit remaining after covering all operating expenses. Analyzing historical net margins allows for the rapid identification of yield compression during shifts in market cycles. This metric measures overall resource management efficiency and the business's ability to generate free cash flow. For Revelation Biosciences (REVB), this indicator is critical due to the high risk of clinical trial failure. Negative dynamics here reflect a rapid cash burn in the absence of stable revenues.

Competitors of Revelation Biosciences (REVB)

argenx (ARGX) - Net Margin|BNTX - Company Sales Margin|ABVX (Abivax Pharma) - Net Sales Margin|Return on Sales by Net Profit ADMA Bio (ADMA)|Return on Sales by Net Profit PTGX (Protagonist Therapeutics Inc)|Net Sales Margin immunovant.com (IMVT)|Net Margin kiniksa.com KNSA|Grifols SA (GRFS) - Net Margin|Adaptive Biotechnologies Inc. - Net Sales Margin|Net Margin Celldex Therapeutics|AUPH: Net Sales Margin|BCRX - Company Sales Margin|VERA (Vera Corp) - Net Sales Margin|Dianthus Pharma (DNTH) - Company Sales Margin|Net Margin Pharvaris Pharma (PHVS)|Net Sales Margin AbCellera Corp (ABCL)|Net Sales Margin TRML (Tourmaline Bio Inc)|Company Sales Margin precigen.com (PGEN)|PHAR - Net Margin|Net Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Sales by Net Profit|Zenas Corp (ZBIO) - Net Sales Margin|Return on Sales by Net Profit IMNM|GOSS: Net Profit Rate|Net Margin KalVista Pharma (KALV)|SEPN - Net Margin|Net Sales Margin PVLA (pieris.com)|Net Sales Margin Savara Pharma SVRA|RIGL: Return on Sales by Net Profit|ANAB - Net Sales Margin|ATXS: Net Sales Margin|ENGN - Company Sales Margin|Return on Sales by Net Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Company Net Profitability|Net Sales Margin ACRS|Return on Sales by Net Profit kyvernatx.com KYTX|Net Sales Margin TLSA (Tiziana Life Sciences, Ltd.)|Net Sales Margin Cabaletta Bio CABA|VTYX: Return on Sales by Net Profit|Theratechnologies Inc. (THTX) - Return on Sales by Net Profit|AVTX: Net Sales Margin|ELDN - Company Sales Margin|AGEN (Agenus, Inc) - Net Sales Margin|Net Sales Margin Climb Bio, Inc.|Net Margin Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Net Profit Rate|Net Sales Margin ADAG (Adagene Inc)|IMA - Return on Sales by Net Profit|STTK - Net Margin|EQ (equilliumbio.com) - Net Return on Sales|CNTB: Net Sales Margin|Immunic Inc (IMUX) - Net Sales Margin|ATRA (Atara Biotherapeutics Inc) - Net Sales Margin|Net Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Net Profit Rate|Adicet Bio, Inc. - Net Return on Sales|Celularity Inc - Return on Sales by Net Profit|Net Sales Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Net Sales Margin|Kezar Life Sciences, Inc. (KZR) - Return on Sales by Net Profit|SAB Biotherapeutics Inc. (SABS) - Net Margin|Return on Sales by Net Profit Akari Therapeutics plc|Net Margin enlivex.com|q32bio.com (QTTB) - Company Sales Margin|Net Sales Margin GOVX|Edesa Biotech, Inc. - Net Return on Sales|iBio Inc - Return on Sales by Net Profit|Net Sales Margin Carisma Therapeutics CARM|XTLB - Net Margin|BOLT (boltbio.com) - Net Return on Sales|HCWB: Net Sales Margin|Aptevo (APVO) - Net Sales Margin|Net Margin AIM ImmunoTech|Return on Sales by Net Profit Aditxt (ADTX)|Return on Sales by Net Profit GRI (GRI Bio Corporation)|XORTX - Net Return on Sales|Net Sales Margin HIND (Vyome Holdings Inc.)|INDP: Net Return on Sales|SCNI - Net Margin|CALI (calcimedica.com) - Net Return on Sales|AFMD (Affimed Therapeutics) - Return on Sales by Net Profit|Allakos Therapeutics (ALLK) - Net Sales Margin|HOOK (HOOKIPA) - Net Sales Margin|igmbio.com (IGMS) - Company Sales Margin|Net Sales Margin ITOS|OCEA (Ocean Biomedical) - Net Profit Rate|Net Sales Margin TCBP (TC BioPharm (Holdings) PLC)|THRD - Return on Sales by Net Profit